Table 2.
Table 2 Second generation antipsycotic agents and metabolic abnormalities (14, 41, 107-109)
| Antipsychotic | Weight gain | Risk for diabetes | Worsening |
| lipid profile | |||
| Clozapine | +++ | + | + |
| Olanzapine | +++ | + | + |
| Risperidone | ++ | ? | ? |
| Quetiapine | ++ | ? | ? |
| Aripiprazole | ± | No report | No report |
| Ziprasidone | ± | No report | No report |
| Amisulpride | ± | No report | No report |